Benlysta (belimumab)

pCPA File Number: 22206

Negotiation Status:

Concluded with an LOI

Indication(s):

Active lupus nephritis

Sponsor/Manufacturer:

GlaxoSmithKline Inc.

CDA-AMC Project Number:

SR0746-000

pCPA Engagement Letter Issued:

2023-04-24

Negotiation Process Concluded:

2024-01-18